|
Real-time
OTC Markets
15:10:47 2026-02-02 EST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | +9,900.00% |
| 12-28 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 25-10-21 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Business description: Seelos Therapeutics, Inc.
Number of employees: 8
Sales by Activity: Seelos Therapeutics, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) |
|---|---|---|---|---|---|
Pharmaceuticals | 375K | - | - | - | 2.2M |
Geographical breakdown of sales: Seelos Therapeutics, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) |
|---|---|---|---|---|---|
United States | 375K | - | - | - | 2.2M |
Executive Committee: Seelos Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 66 | 2018-12-31 |
| Director of Finance/CFO | 54 | 2021-08-31 | |
Gopal Krishna
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Marciano
IRC | Investor Relations Contact | - | 2018-12-31 |
Company details: Seelos Therapeutics, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +9,900.00% | -100.00% | 136 | |
| -1.66% | -4.96% | +49.84% | +88.43% | 69.54B | |
| -2.19% | +1.32% | +44.54% | +88.38% | 64.97B | |
| -3.57% | -4.24% | +47.11% | +5.60% | 26.51B | |
| +1.89% | -2.46% | -16.77% | +452.44% | 25.89B | |
| -0.99% | -10.43% | +0.43% | -16.44% | 25.64B | |
| -9.71% | -0.36% | +245.87% | +377.68% | 20.22B | |
| -1.58% | +0.47% | +29.35% | -19.62% | 19.98B | |
| -3.36% | -7.58% | +9.47% | +535.81% | 15.69B | |
| -0.19% | -0.37% | +46.18% | +142.74% | 13.49B | |
| Average | -2.13% | -3.33% | +1,035.60% | +155.50% | 28.19B | |
| Weighted average by Cap. | -2.17% | -3.50% | +47.94% | +145.09% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SEELQ Stock
- Company Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
